IL262405A - Methods for preparing obeticholic acid and its derivatives - Google Patents

Methods for preparing obeticholic acid and its derivatives

Info

Publication number
IL262405A
IL262405A IL262405A IL26240518A IL262405A IL 262405 A IL262405 A IL 262405A IL 262405 A IL262405 A IL 262405A IL 26240518 A IL26240518 A IL 26240518A IL 262405 A IL262405 A IL 262405A
Authority
IL
Israel
Prior art keywords
derivatives
preparation
methods
obeticholic acid
obeticholic
Prior art date
Application number
IL262405A
Other languages
English (en)
Hebrew (he)
Original Assignee
Intercept Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercept Pharmaceuticals Inc filed Critical Intercept Pharmaceuticals Inc
Publication of IL262405A publication Critical patent/IL262405A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL262405A 2016-04-19 2018-10-16 Methods for preparing obeticholic acid and its derivatives IL262405A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662324405P 2016-04-19 2016-04-19
PCT/US2017/028130 WO2017184598A1 (en) 2016-04-19 2017-04-18 Methods for the preparation of obeticholic acid and derivatives thereof

Publications (1)

Publication Number Publication Date
IL262405A true IL262405A (en) 2018-12-31

Family

ID=60116337

Family Applications (1)

Application Number Title Priority Date Filing Date
IL262405A IL262405A (en) 2016-04-19 2018-10-16 Methods for preparing obeticholic acid and its derivatives

Country Status (14)

Country Link
US (1) US10550146B2 (OSRAM)
EP (1) EP3445370B1 (OSRAM)
JP (1) JP2019515906A (OSRAM)
KR (1) KR20180134405A (OSRAM)
CN (1) CN109069517A (OSRAM)
AR (1) AR108237A1 (OSRAM)
AU (1) AU2017254480A1 (OSRAM)
BR (1) BR112018071441A2 (OSRAM)
CA (1) CA3021322A1 (OSRAM)
ES (1) ES2907425T3 (OSRAM)
IL (1) IL262405A (OSRAM)
MX (1) MX374550B (OSRAM)
TW (1) TW201738254A (OSRAM)
WO (1) WO2017184598A1 (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108299539B (zh) * 2018-03-09 2021-07-06 中山百灵生物技术股份有限公司 利用连续流微反应器生产6-亚乙基鹅去氧胆酸的方法
CN110204587B (zh) * 2019-07-19 2020-05-12 中山百灵生物技术有限公司 一种奥贝胆酸的合成方法
CN113387992A (zh) * 2020-03-11 2021-09-14 成都倍特药业股份有限公司 奥贝胆酸杂质及其制备方法和检测方法
KR20230044603A (ko) 2021-09-27 2023-04-04 (주) 테라베스트 약물 이합체를 포함하는 나노입자 및 이의 용도

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1895945A (en) * 1928-12-20 1933-01-31 Goodrich Co B F Method of making aldehyde-amines
DE60205891T2 (de) 2001-03-12 2006-06-22 Intercept Pharmaceuticals, Inc. Steroide als agonisten für fxr
EP1568706A1 (en) * 2004-02-26 2005-08-31 Intercept Pharmaceuticals, Inc. Novel steroid agonist for FXR
ITMI20050912A1 (it) 2005-05-19 2006-11-20 Erregierre Spa Processo di preparazione di acidi 3-a-ya(b)-diidrossi-6-a(b)-alchil-5b-colanici
PT3336097T (pt) * 2012-06-19 2020-10-29 Intercept Pharmaceuticals Inc Preparação da forma não cristalina de ácido obeticólico
CN108250264A (zh) * 2012-10-26 2018-07-06 英特塞普特医药品公司 制备胆汁酸衍生物的方法
CN104672290B (zh) * 2015-01-05 2017-06-06 北京普禄德医药科技有限公司 一种用于预防或治疗fxr‑介导的疾病的药物及其制备方法和用途
CN106046095B (zh) 2016-06-06 2017-02-22 南京理工大学 奥贝胆酸的合成方法

Also Published As

Publication number Publication date
BR112018071441A2 (pt) 2019-02-05
AU2017254480A1 (en) 2018-11-15
JP2019515906A (ja) 2019-06-13
US10550146B2 (en) 2020-02-04
AR108237A1 (es) 2018-08-01
ES2907425T3 (es) 2022-04-25
EP3445370B1 (en) 2021-12-01
CN109069517A (zh) 2018-12-21
WO2017184598A1 (en) 2017-10-26
MX2018012777A (es) 2019-01-28
EP3445370A1 (en) 2019-02-27
US20190211052A1 (en) 2019-07-11
MX374550B (es) 2025-03-06
CA3021322A1 (en) 2017-10-26
EP3445370A4 (en) 2019-12-25
KR20180134405A (ko) 2018-12-18
TW201738254A (zh) 2017-11-01

Similar Documents

Publication Publication Date Title
IL304455A (en) Methods and intermediates for the preparation of bile acid derivatives
IL258922A (en) Methods for the preparation of obeticholic acid and derivatives thereof
IL257235A (en) Methods for preparation of bile acids and derivatives thereof
IL258113A (en) Methods and intermediates for the preparation bile acid derivatives
EP3468973A4 (en) SOLID FORMS OF VENETOCLAX AND METHOD FOR PRODUCING VENETOCLAX
IL250744A0 (en) A method for preparing flavociclib and its pharmaceutical preparations
EP3288958A4 (en) Compositions of obeticholic acid and methods of use
IL261414B (en) Solid state forms of venetoclax and processes for preparation of venetoclax
GB201817116D0 (en) Pharmaceutical preparation of palbociclic and preparation method thereof
PT3580219T (pt) Processo para a preparação de remimazolam e formas de estado sólido de sais de remimazolam
EP3129024A4 (en) Nicotine formulations and methods of making the same
EP3096763A4 (en) Novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof
GB201519128D0 (en) Solid forms and methods of preparing the same
IL256971A (en) Methods for preparation of bile acids and derivatives thereof
ZA201708429B (en) Oral solid formulation containing irinotecan and method of preparing the same
IL266132A (en) Pharmacological formulations and methods for their preparation
PL3398598T3 (pl) Pochodne sulfonoamidowe oraz sposoby ich wytwarzania i zastosowanie
EP3448375C0 (en) BENZOYLGLYCINE DERIVATIVES AND METHODS OF PRODUCING AND USING SUCH DERIVATIVES
EP3227298A4 (en) Process for the preparation of baricitinib and an intermediate thereof
IL262405A (en) Methods for preparing obeticholic acid and its derivatives
SG10202008700VA (en) α-TRUXILLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF
PL3327012T3 (pl) Krystaliczne postacie bilastyny i sposoby ich wytwarzania
EP3248981A4 (en) C14-hydroxyl esterified amino acid derivatives of triptolide, and preparation method and use thereof
IL260070B (en) A method for the preparation of converted 2-aryl-ethanols
ZA201608823B (en) Processes for the preparation of azd5363 and novel intermediate used therein